Volatility coming to MDMAMDMA is sideways and healthy consolidation so far, need to keep 12c support and want to see a break above 13.5c soon. Two daily inside bars in a row tells me volatility is coming when this tight range breaks.
I publish regular technical analysis of the psychedelic sector. Be sure to like and foll
−0.020 CAD
−823.60 K CAD
1.04 M CAD
94.66 M
About PharmAla Biotech Holdings, Inc.
Sector
Industry
CEO
Nicholas Kadysh
Website
Headquarters
Toronto
ISIN
CA71719L1067
FIGI
BBG014H7BPY1
PharmAla Biotech Holdings, Inc. is a biotechnology company, which engages in the research, development, and manufacturing of MDXX class molecules, including MDMA. It also provides manufacturing of active pharmaceutical ingredient (API) and drug product formulation. The company was founded on January 12, 2021 and is headquartered in Toronto, Canada.
Related stocks
MDMA forming a daily bullflag setupThis is a daily bullflag unless bears prove otherwise. Bulls trying to hold 13c as the new daily higher low. Daily EMA12 is catching up to us and anticipated to also provide support. Backtest on the pullback found support at the daily 50SMA which has been an important moving average in the past.
MDMA bulls charging hard Another huge day after yesterday's giant breakout, more than tripling yesterday's volume. Today had the first sign of some sellers on the tape, which is entire expected after a 60% move, but the sellers did nothing to stop the buying pressure closing half a cent off the high. Congrats to the bulls
MDMA got the BIG breakout we were watching for!Today's the day - we got the HUGE BREAKOUT we started looking for a week or two ago. Here's my analysis of the levels, as well as the reason I am in no hurry to sell
I publish regular technical analysis of the shrooms sector, be sure to like and follow so you don't miss future updates!
PharmAla Biotech Getting Very Tight, powerful break is imminentMDMA PharmAla Biotech Getting Very Tight, break is imminent. I have a bullish lean on this given the bullish tailwinds in the sector, the ramping up of bull volume on the weekly chart, and the lower wicks that look like accumulation to me on the monthly timeframe
I post regular analysis of the psyc
PHARMALA BIOTECH HOLDINGS INC(#MDMA))Hi Dude
from now on i am going to scrutinize Canada Stock market Shares
for This post I Analyze MDMA Share
as Depicted in picture i suggest:
Entry:0.295
SL:0.245
TP= 1:7 but dont hurry and wait for breaking orange trendline
if you like please support by comment and share
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MDMA is 0.115 CAD — it has increased by 4.55% in the past 24 hours. Watch PharmAla Biotech Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange PharmAla Biotech Holdings, Inc. stocks are traded under the ticker MDMA.
MDMA stock has risen by 9.52% compared to the previous week, the month change is a −11.54% fall, over the last year PharmAla Biotech Holdings, Inc. has showed a 27.78% increase.
MDMA reached its all-time high on May 2, 2023 with the price of 0.540 CAD, and its all-time low was 0.020 CAD and was reached on May 11, 2022. View more price dynamics on MDMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MDMA stock is 8.70% volatile and has beta coefficient of 1.35. Track PharmAla Biotech Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is PharmAla Biotech Holdings, Inc. there?
Today PharmAla Biotech Holdings, Inc. has the market capitalization of 12.15 M, it has increased by 4.76% over the last week.
Yes, you can track PharmAla Biotech Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
MDMA net income for the last quarter is −524.24 K CAD, while the quarter before that showed −810.77 K CAD of net income which accounts for 35.34% change. Track more PharmAla Biotech Holdings, Inc. financial stats to get the full picture.
No, MDMA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PharmAla Biotech Holdings, Inc. EBITDA is −1.89 M CAD, and current EBITDA margin is −57.56%. See more stats in PharmAla Biotech Holdings, Inc. financial statements.
Like other stocks, MDMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PharmAla Biotech Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PharmAla Biotech Holdings, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PharmAla Biotech Holdings, Inc. stock shows the sell signal. See more of PharmAla Biotech Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.